Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
ISSN: 2155-9570
Jerry Katzman
USA
Scientific Tracks Abstracts: J Clin Exp Ophthalmol
A 200 degree FOV ophthalmic imaging camera screening device. The device would be affordable and easy to use by not only by Ophthalmologists, Optometrists, Opticians, and eye care professionals but by other medical specialties as well to prevent blindness. General practitioners, pediatricians and hospitals are screening sites. The imaging system would allow for retinal imaging fast, efficient, easy to operate and through an undilated pupil for mass screening. As the earliest signs of diabetes is detected by vascular changes in the peripheral retina and diabetes is the most common cause of blindness, early detection would reduce the dire onset of diabetic retinopathy DR, macula edema DME.
Jerry Katzman is the Company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Katzman has always been an entrepreneur, scientist, and pioneer in medical science. His focus has targeted various biotechnology companies, biopharma, and Wall Street. Upon completion of his medical training, Katzman joined a multi-specialty group practice in Brandon, FL where he founded and established the group’s department of ophthalmology. Katzman graduated from Boston University with a B.S. in Biomedical Engineering in 1974 and thereafter earned his M.D. from the Universidad de Guadalajara in Jalisco, Mexico